Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
Following publication of the original article [1], we have been notified that end note would need to be adjusted.
Main Authors: | Wesley de Jong, Joeri Aerts, Sabine Allard, Christian Brander, Jozefien Buyze, Eric Florence, Eric van Gorp, Guido Vanham, Lorna Leal, Beatriz Mothe, Kris Thielemans, Montse Plana, Félipe Garcia, Rob Gruters, on behalf of the iHIVARNA consortium |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | Trials |
Online Access: | https://doi.org/10.1186/s13063-019-3940-0 |
Similar Items
-
iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
by: Wesley de Jong, et al.
Published: (2019-06-01) -
Increases in condomless chemsex associated with HIV acquisition in MSM but not heterosexuals attending a HIV testing center in Antwerp, Belgium
by: Chris Kenyon, et al.
Published: (2018-10-01) -
HIV prevalence by race co-varies closely with concurrency and number of sex partners in South Africa.
by: Chris Kenyon, et al.
Published: (2013-01-01) -
Strong association between higher-risk sex and HIV prevalence at the regional level: an ecological study of 27 sub-Saharan African countries [version 1; referees: 2 approved]
by: Chris R. Kenyon, et al.
Published: (2018-12-01) -
The Prevalence of HIV by Ethnic Group Is Correlated with HSV-2 and Syphilis Prevalence in Kenya, South Africa, the United Kingdom, and the United States
by: Chris Richard Kenyon, et al.
Published: (2014-01-01)